DK0883596T3 - Fluoreret propranolol og dermed beslægtede fremgangsmåder - Google Patents
Fluoreret propranolol og dermed beslægtede fremgangsmåderInfo
- Publication number
- DK0883596T3 DK0883596T3 DK96940758T DK96940758T DK0883596T3 DK 0883596 T3 DK0883596 T3 DK 0883596T3 DK 96940758 T DK96940758 T DK 96940758T DK 96940758 T DK96940758 T DK 96940758T DK 0883596 T3 DK0883596 T3 DK 0883596T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluorinated
- propranolol
- presented
- drugs
- antioxidant
- Prior art date
Links
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical class C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 title abstract 5
- 230000003078 antioxidant effect Effects 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960003712 propranolol Drugs 0.000 abstract 2
- 239000002876 beta blocker Substances 0.000 abstract 1
- 229940097320 beta blocking agent Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US683595P | 1995-11-16 | 1995-11-16 | |
| US879095P | 1995-12-18 | 1995-12-18 | |
| PCT/US1996/017679 WO1997018184A1 (en) | 1995-11-16 | 1996-11-16 | Fluorinated propranolol and related methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0883596T3 true DK0883596T3 (da) | 2002-01-21 |
Family
ID=26676127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96940758T DK0883596T3 (da) | 1995-11-16 | 1996-11-16 | Fluoreret propranolol og dermed beslægtede fremgangsmåder |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5776985A (da) |
| EP (1) | EP0883596B1 (da) |
| JP (1) | JP2000500451A (da) |
| AT (1) | ATE205470T1 (da) |
| DE (1) | DE69615221T2 (da) |
| DK (1) | DK0883596T3 (da) |
| ES (1) | ES2163661T3 (da) |
| PT (1) | PT883596E (da) |
| WO (1) | WO1997018184A1 (da) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL300886A (da) * | 1962-11-23 |
-
1996
- 1996-11-14 US US08/748,894 patent/US5776985A/en not_active Expired - Fee Related
- 1996-11-16 WO PCT/US1996/017679 patent/WO1997018184A1/en not_active Ceased
- 1996-11-16 PT PT96940758T patent/PT883596E/pt unknown
- 1996-11-16 AT AT96940758T patent/ATE205470T1/de not_active IP Right Cessation
- 1996-11-16 DE DE69615221T patent/DE69615221T2/de not_active Expired - Fee Related
- 1996-11-16 ES ES96940758T patent/ES2163661T3/es not_active Expired - Lifetime
- 1996-11-16 JP JP9518905A patent/JP2000500451A/ja not_active Ceased
- 1996-11-16 DK DK96940758T patent/DK0883596T3/da active
- 1996-11-16 EP EP96940758A patent/EP0883596B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0883596B1 (en) | 2001-09-12 |
| US5776985A (en) | 1998-07-07 |
| DE69615221T2 (de) | 2002-06-13 |
| EP0883596A4 (en) | 1999-05-06 |
| EP0883596A1 (en) | 1998-12-16 |
| WO1997018184A1 (en) | 1997-05-22 |
| JP2000500451A (ja) | 2000-01-18 |
| PT883596E (pt) | 2002-02-28 |
| DE69615221D1 (de) | 2001-10-18 |
| ATE205470T1 (de) | 2001-09-15 |
| ES2163661T3 (es) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9301634A (es) | Quinuclidinas peptidicas. | |
| ES2191192T3 (es) | Tienopirimidinas. | |
| FI875326A7 (fi) | Valonsäteilyttäjälaite korvan lääketieteelliseen hoitoon. | |
| ES2152483T3 (es) | Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b. | |
| GR3031659T3 (en) | Enniatines and enniatine derivates used to control endoparasites. | |
| TR199901174T2 (xx) | Yeni heterosiklilmetil-ikameli pirazol t�revleri. | |
| ITRM920155A0 (it) | Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi. | |
| MXPA02007915A (es) | Mediador de lipido activado por aspirina. | |
| ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
| IT8023749A0 (it) | Protesi anulare regolabile per chirurgia cardiaca. | |
| ES2182837T3 (es) | Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus. | |
| ES2071486T3 (es) | Derivado de la 5h-pirrolo(3,4-b)pirazina opticamente activa, su preparacion y las composiciones farmaceuticas que le contienen. | |
| ES2161697T3 (es) | Peptidos agonistas de amilina y usos de los mismos. | |
| FI832040L (fi) | Byggbart borr | |
| ES2119912T3 (es) | Nuevos aminometilenpeptidos como inmunosupresores. | |
| ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| ES2192839T3 (es) | Timosina beta 4 oxidada. | |
| DK0725637T3 (da) | Parenteralt busulfan til behandling af malign sygdom | |
| ES2164914T3 (es) | Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar. | |
| ES2120962T3 (es) | Composicion antivirica. | |
| DK0662837T3 (da) | Anvendelse af IL-10 til forhindring af insulinafhængig diabetes mellitus | |
| EA199900450A1 (ru) | Агент, индуцирующий апоптоз | |
| AR008860A1 (es) | Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica | |
| DK578887A (da) | Antihypertensiva |